SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001091818-20-000228
Filing Date
2020-10-23
Accepted
2020-10-23 12:23:19
Documents
36
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 QTR. REPORT - SEPT. 30, 2020 bfnh1020202010qsept2020.htm 10-Q 195209
2 CERTIFICATION ex311.htm EX-31.1 4758
3 CERTIFICATION ex312.htm EX-31.2 4959
4 CERTIFICATION ex321.htm EX-32.1 2026
5 CERTIFICATION ex322.htm EX-32.2 1937
12 bfnhlogo2019001.jpg GRAPHIC 21193
  Complete submission text file 0001091818-20-000228.txt   1132387

Data Files

Seq Description Document Type Size
6 bfnh-20200930.xml EX-101.INS 101563
7 bfnh-20200930.xsd EX-101.SCH 15603
8 bfnh-20200930_cal.xml EX-101.CAL 24481
9 bfnh-20200930_def.xml EX-101.DEF 52367
10 bfnh-20200930_lab.xml EX-101.LAB 112945
11 bfnh-20200930_pre.xml EX-101.PRE 91518
Mailing Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454
Business Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454 757-306-6090
BIOFORCE NANOSCIENCES HOLDINGS, INC. (Filer) CIK: 0001310488 (see all company filings)

IRS No.: 852138858 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51074 | Film No.: 201256864
SIC: 3826 Laboratory Analytical Instruments